Evolution of poliovirus defective interfering particles expressing Gaussia luciferase

Journal of Virology

Volumn 86, Issue 4, 2012, Pages 1999-2010

  Song, Yutong ^a   Paul, Aniko V ^a   Wimmer, Eckard ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GAUSSIA LUCIFERASE PROTEIN; LUCIFERASE; POLYPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CHIMERA; COEVOLUTION; CONTROLLED STUDY; DEFECTIVE VIRUS; GENETIC CODE; HELA CELL; HUMAN; HUMAN CELL; MAMMAL CELL; MOLECULAR EVOLUTION; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REPORTER GENE; RNA REPLICATION; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS MORPHOGENESIS; VIRUS PARTICLE; WILD TYPE;

ANIMALS; BIOLOGICAL EVOLUTION; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CRUSTACEA; DEFECTIVE VIRUSES; GENE EXPRESSION; GENES, REPORTER; LUCIFERASES; POLIOVIRUS; POLYPROTEINS; RECOMBINANT FUSION PROTEINS;

ENTEROVIRUS; MAMMALIA; MIRIDAE; POLIOVIRUS; RENILLA LUCIFERASE;

EID: 84863120549     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05871-11     Document Type: Article

References (73)

1. Agol VI, Gmyl AP. 2010. Viral security proteins: counteracting host defences. Nat. Rev. Microbiol. 8:867-878.
2. Aldabe R, Barco A, Carrasco L. 1996. Membrane permeabilization by poliovirus proteins 2B and 2BC. J. Biol. Chem. 271:23134-23137.
3. Alexander L, Lu HH, Gromeier M, Wimmer E. 1994. Dicistronic polioviruses as expression vectors for foreign genes. AIDS Res. Hum. Retroviruses 10(Suppl 2):S57-S60.
4. Andino R, Rieckhof GE, Achacoso PL, Baltimore D. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 12:3587-3598.
5. Badr CE, Hewett JW, Breakefield XO, Tannous BA. 2007. A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS One 2:e571.
6. Belov GA, et al. 2007. Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. J. Virol. 81:558-567.
7. Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E. 2008. A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog. 4:e1000216.
8. Beske O, Reichelt M, Taylor MP, Kirkegaard K, Andino R. 2007. Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J. Cell Sci. 120: 3207-3218.
9. Bienz K, Egger D, Pasamontes L. 1987. Association of polioviral proteins of the P2 genomic region with the viral replication complex and virusinduced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160:220-226.
10. Bienz K, Egger D, Pfister T, Troxler M. 1992. Structural and functional characterization of the poliovirus replication complex. J. Virol. 66:2740-2747.
11. Bienz K, Egger D, Troxler M, Pasamontes L. 1990. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J. Virol. 64:1156-1163.
12. Choe SS, Dodd DA, Kirkegaard K. 2005. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337:18-29.
13. Cole CN, Baltimore D. 1973. Defective interfering particles of poliovirus. 3. Interference and enrichment. J. Mol. Biol. 76:345-361.
14. Cole CN, Smoler D, Wimmer E, Baltimore D. 1971. Defective interfering particles of poliovirus. I. Isolation and physical properties. J. Virol. 7:478-485.
15. Collis PS, O'Donnell BJ, Barton DJ, Rogers JA, Flanegan JB. 1992. Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J. Virol. 66:6480-6488.
16. Cornell CT, Brunner JE, Semler BL. 2004. Differential rescue of poliovirus RNA replication functions by genetically modified RNA polymerase precursors. J. Virol. 78:13007-13018.
17. Cornell CT, Kiosses WB, Harkins S, Whitton JL. 2006. Inhibition of protein trafficking by coxsackievirus B3: multiple viral proteins target a single organelle. J. Virol. 80:6637-6647.
18. Dales S, Eggers HJ, Tamm I, Palade GE. 1965. Electron microscopic study of the formation of poliovirus. Virology 26:379-389.
19. Deitz SB, Dodd DA, Cooper S, Parham P, Kirkegaard K. 2000. MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc. Natl. Acad. Sci. U. S. A. 97:13790-13795.
20. DeWet JR, Wood KV, Helinski DR, DeLuca M. 1985. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 82:7870-7873.
21. Dodd DA, Giddings TH, Jr, Kirkegaard K. 2001. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J. Virol. 75:8158-8165.
22. Doedens J, Maynell LA, Klymkowsky MW, Kirkegaard K. 1994. Secretory pathway function, but not cytoskeletal integrity, is required in poliovirus infection. Arch. Virol. Suppl. 9:159-172.
23. Doedens JR, Giddings TH, Jr, Kirkegaard K. 1997. Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J. Virol. 71:9054-9064.
24. Doedens JR, Kirkegaard K. 1995. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14:894-907.
25. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. 2002. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76:4430-4440.
26. Fujita K, et al. 2007. Membrane topography of the hydrophobic anchor sequence of poliovirus 3A and 3AB proteins and the functional effect of 3A/3AB membrane association upon RNA replication. Biochemistry 46: 5185-5199.
27. Hagino-Yamagishi K, Nomoto A. 1989. In vitro construction of poliovirus defective interfering particles. J. Virol. 63:5386-5392.
28. Henle W, Henle G. 1943. Interference of inactive virus with the propagation of virus of influenza. Science 98:87-89.
29. Hsu NY, et al. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799-811.
30. Huang AS, Baltimore D. 1970. Defective viral particles and viral disease processes. Nature 226:325-327.
31. Jang SK, Davies MV, Kaufman RJ, Wimmer E. 1989. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virusRNAin vivo. J. Virol. 63:1651-1660.
32. Kajigaya S, et al. 1985. Isolation and characterization of defectiveinterfering particles of poliovirus Sabin 1 strain. Virology 142:307-316.
33. Kirkegaard K. 1992. Genetic analysis of picornaviruses. Curr. Opin. Genet. Dev. 2:64-70.
34. Kirkegaard K. 1990. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J. Virol. 64:195-206.
35. Knappskog S, et al. 2007. The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide. J. Biotechnol. 128:705-715.
36. Kuge S, Saito I, Nomoto A. 1986. Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J. Mol. Biol. 192:473-487.
37. Liu Y, et al. 2010. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog. 6:e1001066.
38. Lorenz WW, McCann RO, Longiaru M, Cormier MJ. 1991. Isolation and expression of a cDNA encoding Renilla reniformis luciferase. Proc. Natl. Acad. Sci. U. S. A. 88:4438-4442.
39. Lu HH, Alexander L, Wimmer E. 1995. Construction and genetic analysis of dicistronic polioviruses containing open reading frames for epitopes of human immunodeficiency virus type 1 gp120. J. Virol. 69: 4797-4806.
40. Matthews JC, Hori K, Cormier MJ. 1977. Purification and properties of Renilla reniformis luciferase. Biochemistry 1:85-91.
41. Mattion NM, et al. 1995. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D. J. Virol. 69:5132-5137.
42. Miller S, Krijnse-Locker J. 2008. Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 6:363-374.
43. Moffat K, et al. 2005. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J. Virol. 79:4382-4395.
44. Moffat K, et al. 2007. Inhibition of the secretory pathway by foot-andmouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J. Virol. 81:1129-1139.
45. Molla A, Paul AV, Wimmer E. 1991. Cell-free, de novo synthesis of poliovirus. Science 254:1647-1651.
46. Mueller S, Wimmer E. 1998. Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames. J. Virol. 72:20-31.
47. Neznanov N, et al. 2001. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J. Virol. 75:10409-10420.
48. Nomoto A, Jacobson A, Lee YF, Dunn J, Wimmer E. 1979. Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region. J. Mol. Biol. 128:179-196.
49. Novak JE, Kirkegaard K. 1994. Coupling between genome translation and replication in an RNA virus. Genes Dev. 8:1726-1737.
50. Nugent CI, Johnson KL, Sarnow P, Kirkegaard K. 1999. Functional coupling between replication and packaging of poliovirus replicon RNA. J. Virol. 73:427-435.
51. Paul AV, Molla A, Wimmer E. 1994. Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C. Virology 199:188-199.
52. Pelham HR. 1991. Multiple targets for brefeldin A. Cell 67:449-451.
53. Pfister T, Wimmer E. 1999. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J. Biol. Chem. 274:6992-7001.
54. Porter DC, et al. 1998. Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase. Virology 243:1-11.
55. Richards OC, Ehrenfeld E. 1990. Poliovirus RNA replication. Curr. Top. Microbiol. Immunol. 161:89-119.
56. Salonen A, Ahola T, Kaariainen L. 2005. Viral RNA replication in association with cellular membranes. Curr. Top. Microbiol. Immunol. 285: 139-173.
57. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO. 2005. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 11:435-443.
58. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E. 1997. Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J. Virol. 71:8962-8972.
59. Teterina NL, et al. 2011. Identification of tolerated insertion sites in poliovirus non-structural proteins. Virology 409:1-11.
60. Teterina NL, Levenson EA, Ehrenfeld E. 2010. Viable polioviruses that encode 2A proteins with fluorescent protein tags. J. Virol. 84:1477-1488.
61. Teterina NL, Pinto Y, Weaver JD, Jensen KS, Ehrenfeld E. 2011. Analysis of poliovirus protein 3A interactions with viral and cellular proteins in infected cells. J. Virol. 85:4284-4296.
62. Towner JS, Ho TV, Semler BL. 1996. Determinants of membrane association for poliovirus protein 3AB. J. Biol. Chem. 271:26810-26818.
63. van der Werf S, Bradley J, Wimmer E, Studier FW, Dunn JJ. 1986. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 83:2330-2334.
64. van Kuppeveld FJ, Melchers WJ, Kirkegaard K, Doedens JR. 1997. Structure-function analysis of coxsackie B3 virus protein 2B. Virology 227:111-118.
65. Verhaegent M, Christopoulos TK. 2002. Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal. Chem. 74:4378-4385.
66. Von Magnus P. 1954. Incomplete forms of influenza virus. Adv. Virus Res. 2:59-78.
67. Wessels E, et al. 2006. Effects of picornavirus 3A proteins on protein transport and GBF1-dependent COP-I recruitment. J. Virol. 80:11852-11860.
68. Wessels E, et al. 2006. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev. Cell 11:191-201.
69. Wessels E, Duijsings D, Notebaart RA, Melchers WJ, van Kuppeveld FJ. 2005.Aproline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-Golgi transport. J. Virol. 79:5163-5173.
70. Wimmer E, Hellen CU, Cao X. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
71. Wimmer E, Paul AV. 2010. The making of a picornavirus genome, p 33-55. In Ehrenfeld E, et al. (ed), The picornaviruses. ASM Press, Washington, DC.
72. Yim TJ, Tang S, Andino R. 1996. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice. Virology 218:61-70.
73. Yin J, Paul AV, Wimmer E, Rieder E. 2003. Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of singleand dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J. Virol. 77:5152-5166.